Deep Venous Thrombosis Screening in the ICU by Nurses

NCT03707665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2019-08-02

No results posted yet for this study

Summary

Despite of preventive measures, the incidence of deep venous thrombosis (DVT) in ICU patients is estimated to range from 5-31%. While clinical diagnostics is unreliable, ultrasound compression test (UCT) has proven to be a highly sensitive and specific modality for the recognition of lower extremity DVT. Delegating this competence to ICU nurses can increase UCT availability and enable preventive DVT screening. Therefore, the investigators decided to conduct a clinical study to evaluate the sensitivity and specificity of UCT performed by general ICU nurse in ICU patients compared to an investigation by ICU physician certified in ultrasound. Prior to the study, each nurse-investigator participating in the study undergo one-hour training in UCT and examine 5 patients under supervision. Then, ICU patients without known DVT will be investigated by UCT in the femoral and popliteal region of both lower extremities by trained general ICU nurse-investigators. On the same day, the examination will be repeated by an ICU physician-investigator. The results of the examinations of each patient will be blinded to each other for both investigators until both tests are performed. The sensitivity and specificity of the test performed by general nurse will be calculated in comparison with the examination by a specialist.

Conditions

  • Deep Venous Thrombosis

Interventions

DIAGNOSTIC_TEST

Compression ultrasound testing

Compression ultrasound testing, screening technique for diagnosing deep venous thrombosis

Sponsors & Collaborators

  • Masaryk Hospital Usti nad Labem

    collaborator OTHER
  • Emergency Medical Service of the Central Bohemian Region, Czech Republic

    lead OTHER

Principal Investigators

  • Roman Skulec, MD, PhD · Department of Anesthesiology, Perioperative Medicine and Intensive Care, J.E. Purkinje University, Masaryk Hospital Usti nad Labem, Usti nad Labem, Czech Republic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2019-04-30
Completion
2019-05-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03707665 on ClinicalTrials.gov